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ABSTRACT Biomimetic systems such as giant unilamellar vesicles (GUVs) are increasingly used for studying protein/lipid inter-
actions due to their size (similar to that of cells) and to their ease of observation by light microscopy techniques. Biophysicists
have begun to complexify GUVs to investigate lipid/protein interactions. In particular, composite GUVs have been designed that
incorporate lipids that play important physiological roles in cellulo, such as phosphoinositides and among those the most abun-
dant one, phosphatidylinositol(4,5)bisphosphate (PIP2). Fluorescent lipids are often used as tracers to observe GUVmembranes
by microscopy but they can not bring quantitative information about the insertion of unlabeled lipids. In this study, we carried out
z-potential measurements to prove the effective incorporation of PIP2 as well as that of phosphatidylserine in the membrane of
GUVs prepared by electroformation and to follow the stability of PIP2-containing GUVs. Using confocal microscopy, we found that
long-chain (C16) ﬂuorescent PIP2 analogs used as tracers (0.1% of total lipids) show a uniform distribution in the membrane
whereas PIP2 antibodies show PIP2 clustering. However, the clustering effect, which is emphasized when tertiary antibodies are
used in addition to secondary ones to enhance the size of the detection complex, is artifactual. We showed that divalent ions
(Ca21 and Mg21) can induce aggregation of PIP2 in the membrane depending on their concentration. Finally, the interaction of
ezrin with PIP2-containing GUVs was investigated. Using either labeled ezrin and unlabeled GUVs or both labeled ezrin and
GUVs, we showed that clusters of PIP2 and proteins are formed.
INTRODUCTION
Phosphoinositides are a particular class of lipids present in
cell membranes that have very important physiological roles
(1). Their structure shares a common inositol ring bearing
one, two, or three phosphate groups and their glycerol moi-
eties link both a saturated and an unsaturated alkyl chain.
Phosphatidylinositol(4,5)bisphosphate (PI(4,5)P2 or PIP2) is
the most abundant phosphoinositide at the plasma mem-
brane. It has the ability to interact with a wide range of
proteins (2–4). It is now well documented that PIP2 regulates
the cytoskeleton/plasma membrane interactions, membrane
trafﬁcking, exocytosis, endocytosis, and the activation of
enzymes (2,5–7). A great deal of work is dedicated to the
understanding of the role of PIP2 in cellulo, using ﬂuorescent
tools (8). In addition, studies in biomimetic systems, in-
cluding large unilamellar vesicles (LUVs) (9,10), supported
lipid bilayers (SLBs) (11,12), and giant unilamellar vesicles
(GUVs) (13,14) have emerged during the past years to elu-
cidate the molecular mechanisms of protein/lipid interactions
in well deﬁned systems composed of a limited number of
constituents. Thus, LUVs allow one to carry out quantitative
determination of afﬁnity constants by co-sedimentation as-
says (15) or ﬂuorescence correlation spectroscopy (16).
In addition, SLBs can be observed by atomic force micro-
scope, allowing one to follow in situ protein/membrane in-
teractions (12) or to visualize lipid domain formation (17).
Nevertheless, GUVs are more ‘‘cell mimics’’ than LUVs and
SLBs as their size (from ;5 to ;40 mm) and membrane
curvature are similar to those of cells and as they can be
observed using a light microscope (18,19). The protocol for
producing LUVs seems rather well established (15) and
various phosphoinositides have already been incorporated in
LUVs (14). Their characterization is possible by means of elec-
trophoretic (i.e., z-potential) measurements to check whether
PIP2 is effectively incorporated in the LUVs. z-Potential
measurements also allow investigations of ion/vesicles (20)
or protein/vesicles interactions (21). Recently, electrophoretic
measurements also were used for measuring the z-potential
of LUVs fabricated from a lipid mixture that contains various
amounts of phosphoinositides (22).
Very generally, the preparation of GUVs is recognized to
be much less straightforward than that of LUVs. Two main
methods for preparing GUVs are widely used: the gentle
hydration method (23) and electroformation (24). The for-
mer, although much simpler, is known to give a poor yield in
unilamellar vesicles and a high percent of vesicles presenting
defects, but it can be used in physiological media (media of
relatively high ionic strength) (25). The latter gives a high
yield of unilamellar vesicles but is restricted to low ionic
strength media due to the application of an electric ﬁeld (25).
Furthermore, it has also been shown that the presence of a too
large fraction of negatively charged lipids does not favor the
doi: 10.1529/biophysj.107.126912
Submitted November 30, 2007, and accepted for publication May 1, 2008.
Address reprint requests to Catherine Picart, E-mail: catherine.picart@
univ-montp2.fr.
Editor: Enrico Gratton.
 2008 by the Biophysical Society
0006-3495/08/11/4348/13 $2.00
4348 Biophysical Journal Volume 95 November 2008 4348–4360
formation of unilamellar vesicles with both methods. In ad-
dition, the size of the GUVs renders them more fragile and
more difﬁcult to manipulate than LUVs. A survey of the
literature indicates that studies on GUVs containing phos-
phoinositides are only emerging (Table 1). The gentle
hydration method has been mostly chosen to prepare PIP2-
containing GUVs (26–28) and only three recent studies used
electroformation (13,14,29) with unlabeled PIP2 and a small
percent of labeled dipyrromethene boron diﬂuoride (BODIPY)
tetramethylrhodamine PIP2 (TMR-PIP2) or BODIPY FL PIP2
(FL-PIP2). However, PIP2 is known to be a micelle-forming
lipid (29,30) due to its large polar headgroup, and short
chains TMR-PIP2 and FL-PIP2 are also known to not parti-
tion easily into a phosphatidylcholine membrane (29). Thus,
it seems important to check, on the one hand, that PIP2 is
effectively incorporated in the membrane of GUVs and, on
the other hand, whether ﬂuorescent PIP2 molecules and PIP2
antibodies are reliable indicators of the incorporation of na-
tive PIP2 within vesicles.
In this work, our aim was to investigate the conditions for
the effective formation of GUVs containing PIP2 by elec-
troformation to subsequently use these GUVs for investi-
gating protein/membrane interactions. As ﬂuorescent lipids
are useful and often needed to carry out confocal microscopy
observations, we will also investigate the conditions for in-
corporation of FL-PIP2 and TMR-PIP2 as tracers in GUVs.
z-Potential measurements on GUVs, direct incorporation of
ﬂuorescently labeled PIP2, and antibody-labeling of GUVs
will prove that PIP2 is effectively and quantitatively incor-
porated in the membrane of GUVs.
Finally, we will show that ezrin, a protein that is known to
interact via its FERM (4.1, ezrin, radixin, moesin) domain
with PIP2 molecules inserted in supported lipid bilayers (12)
and with large unilamellar vesicles containing PIP2 (22), is
able to induced PIP2 reorganization on interaction with the
membrane of GUVs.
MATERIALS AND METHODS
Lipids and buffers
1,2-Dioleoly-sn,-glycero-3-phosphatidylcholine (DOPC) and 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphatidylserine (POPS) were obtained from Avanti
Polar Lipids (Alabaster, AL). Cholesterol (Chol) was obtained from Sigma
(St. Quentin Fallavier, France). The ammonium salt of L-a-phosphatidyli-
nositol(4,5)-bisphosphate (PIP2) was purchased from Lipid Products (Surrey,
Great Britain). The PIP2 is extracted from natural source and thus contains
both unsaturated and saturated acyl chains. BODIPY-TMR-PI(4,5)P2, (TMR-
PIP2, reference C-45M16a for the C16 chain and reference C45-M6a for the
C6 one), BODIPY-FL-PI(4,5)P2 (FL-PIP2, reference C-45F16a for the C16
chain and reference C-45F6a for the C6 one) were purchased from Echelon
Bioscience (Tebu-Bio, Le Perray en Yvelines, France). These BODIPY-PIP2
are ﬂuorescent analogs of PIP2 and contain only saturated alkyl chains with
the dye grafted at one of the alkyl chains (the structures are available at http://
www.echelon-inc.com). Monoclonal antibodies (IgG2B) against PIP2 were
bought from Assay Designs (Ann Arbor, MI). Secondary and tertiary anti-
bodies (rabbit anti-mouse coupled to Alexa 568 (RAM-Alexa 568), unlabeled
goat anti-mouse antibody (GAM), and donkey anti-goat antibody coupled to
Alexa 488 (DAG-Alexa 488)were bought fromMolecular Probes (Eugene, OR).
Ezrin was kept at 4C in a buffer containing 70 mM NaCl, 25 mM 2-(N-
morpholino)ethanesulfonic acid (MES) at pH 6.2 (MES-NaCl buffer). For
experiments with GUVs, the buffer was brought to pH 7.4 with 30 mM Tris
(Ezrin buffer). Vesicles were prepared in a buffer containing sucrose (165
mM sucrose, 2 mMTris, 0.5 mMEGTA, pH¼ 7.4, sucrose buffer) and were
resuspended in a glucose buffer (170 mM glucose, 2 mM Tris, 0.5 mM
EGTA, pH ¼ 7.4, glucose buffer). The osmolarities of the buffers were
checked using an osmometer (Vapro, Wescor, Logan, UT). Wemeasured the
following osmolarities: (173 6 3) mOsm for the sucrose buffer, (180 6 3)
mOsm for the glucose buffer, and (184 6 3) mOsm for the ezrin buffer.
Protein expression, puriﬁcation, and labeling
The expression and puriﬁcation of wild-type (WT) ezrin cloned in the pGEX
2-T vector have already been described (31). Recently, we produced ezrin
with an additional cysteine at its C terminus following two extra glycine
residues (GGC) to covalently couple it to a maleimide ﬂuorophore (22). Both
wild-type ezrin and ezrin-cysteine were obtained using the same puriﬁcation
procedure. Labeling of ezrin-cysteine was carried out using either Alexa488-
C5-maleimide (Alexa488) or Alexa546-C5 maleimide (Alexa546), both
from Molecular Probes. Puriﬁed ezrin conserved in the MES-NaCl buffer
TABLE 1 Summary of the studies investigating protein interactions with PIP2-containing GUVs prepared by the gentle hydration
method or by electroformation
Study GUVs preparation Composition Suspending medium Proteins
Gentle hydration
Takeda et al. (27) 25C in 5 mM Tris-HCl PC/PE/PG/PIP2 KCl buffer
(0–120 mM)
Talin
Tong et al. (51) 37C in 100 mM sucrose DOPC/DOPG/SM/Chol/PIP2/TMR-PIP2 100 mM glucose GAP-43
Golebiewska et al. (28) 35–40C in 100 mM KCl POPC/PS/PIP2 100 mM KCl MARCKS
(151-175)-Alexa488
Heuvingh et al. (45) in 280 mM sucrose DOPC/PIP2 HeLa cell extracts ARF1, Actin
Electroformation
Liu and Fletcher (13) 60C in 350 mOsm sucrose DOPC/DPPC/Chol/TMR-PIP2/PIP2 50 mM KCl N-WASP, Arp2/3, Actin
Gokhale et al. (14) 60C in deionized water POPC/POPE/POPS/PIP2 160 mM NaCl Annexin 2
Moens et al. (29) 45C in 200 mM sucrose POPC/PIP2/TMR-PIP2 (or FL-PIP2, both C6) 200 mM glucose Proﬁlin
PC, phosphatidylcholine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine; PE, phosphatidylethanolamine; POPE, 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphatidylethanolamine; PG, phosphatidylglycerol; DOPG, dipalmitoylphosphatidylglycerol; SM, sphingomyelin; PS, phosphatidylserine;
POPS, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylserine; DPPC, dipalmitoylphosphatidylcholine.
All experiments were carried out at physiological pH (7–7.4).
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was treated with a 10-fold molar excess of Alexa488-C5-maleimide or
Alexa546-C5 maleimide (dissolved in DMSO) for 90 min at room temper-
ature in MES-NaCl buffer. The labeling reaction was subsequently quenched
by adding an excess amount of dithiothreitol and the labeled protein was
separated from the reagents using a Sephadex G25 column (GE Healthcare,
Velizy, France) eluted with the MES-NaCl buffer. The labeling efﬁciency of
ezrin was estimated by determining the respective molar concentration of dye
and of protein and calculating the grafting ratio (molar extinction coefﬁcients
are respectively: e¼ 72,000M1 cm1 for Alexa488 at 495 nm, e¼ 104,000
M1 cm1 for Alexa546 at 544 nm, e ¼ 69 000 M1 cm1 for ezrin at 280
nm). Under our labeling conditions,;0.93 mol of Alexa488 and;0.92 mol
of Alexa546 were incorporated per mol of ezrin.
GUVs and LUVs
GUVs were prepared using the electroformation method ﬁrst described by
Angelova et al. (32). The vesicles were formed using DOPC or DOPC and
cholesterol (15%), with various amounts of PIP2 (from 1% to 10% in weight).
Brieﬂy, 20 mL of lipid mixture at 2.5 mg/mL in chloroform/methanol 2:1
(v/v) were spread on two ITO-coated plates and quickly dried under nitrogen
ﬂow. The slides were placed under vacuum for 2 h to remove traces of or-
ganic solvent. After solvent evaporation, an electroformation chamber was
formed using the ITO plates (their conductive sides facing each other), a
rubber ring, and Vitrex paste to seal the chamber. The chamber was ﬁlled
with ;1.5 mL of sucrose buffer and placed in an incubator at 38C. A
function generator was used to apply an AC voltage at 10 Hz, the voltage
being progressively increased from 200 mV to 1 V within 30 min and kept
constant for the remaining 45 min. Vesicle detachment was then achieved by
decreasing the frequency to 5 Hz for 15 min. GUVs were stored at room
temperature.
LUVswere prepared as described previously (22). Brieﬂy, the appropriate
lipid mixture was dried in a Speedvac rotary evaporator overnight, and the
lipids were rehydrated in the sucrose buffer for 2 h at 37C (interrupted by
rigorous vortexing every 15 min), then extruding the multilamellar vesicles
through a stack of two polycarbonate ﬁlters (100 nm pore size diameter)
using the mini-extruder from Avanti Polar Lipids. Final concentrations of
lipids were measured using the Phospholipid B kit (Wako Chemicals GmbH,
Neuss, Germany) and were within 90–95% of the expected concentration.
LUVs were stored at room temperature at 10 mg/mL lipid concentration.
Light and confocal microscopy observations
For microscopy observations, GUVs were let to sediment in a glucose buffer
with a weakly higher osmolarity than the sucrose buffer such as to slightly
deﬂate the GUVs and render them more ﬂaccid and ﬂuctuating. The obser-
vation chambers were pegylated to prevent attractive interactions between
GUVs and the glass substrate (22). A silicone insulator (P24742, Molecular
Probes) glued to the pegylated glass slides was used to prepare several wells,
whichwere ﬁlled with 15mL of sample. Experiments with the PIP2 antibodies
were carried out in the ezrin buffer. For the experiments with the protein,
GUVs were diluted 1:10 in the ezrin solution. Ezrin total concentration was in
the range 14–22 mM. Confocal microscopy observation of GUVs were car-
ried out on a spinning disk rapid confocal imager Ultra view ERS (Perkin
Elmer, Courtaboeuf, France) with a 633 oil objective (NA ¼ 1.4).
Image analysis
Fluorescent images were analyzed with ImageJ software (http://rsb.info.
nih.gov/ij/). Image superposition was realized by using the «rgb merge»
function of Image J. Using the plug-in «Radial Proﬁle plot», the integrated
intensities along concentric circles (centered at the center of the GUVs) were
measured. For experiments with nonﬂuorescent GUVs immersed in an ezrin
solution containing ﬂuorescently labeled ezrin, the integrated intensity I was
normalized such that the resulting intensity, INORM, was equal to 0 in the
interior of the GUV (where the measured intensity IINT was the noise signal)
and equal to 1 in the external medium (IEXT, where the measured intensity is
the background intensity of the ezrin medium). Hence, the normalized in-
tensities were calculated following INORM ¼ (I  IINT)/(IEXT  IINT).
To quantify the heterogeneous nature of the membrane of GUVs, we
adapted a recently published procedure (33). The principle is that the for-
mation of clusters leads to an increased occurrence of areas with high
(cluster) and low (intercluster) ﬂuorescence intensities. Therefore, cluster
formation results in increased SD of the ﬂuorescence signal. The plug-in
«Oval Proﬁle Plot» was used to extract an azimuthal proﬁle of the equatorial
section of a GUV (along all the GUV contour length, i.e., for 360). The
proﬁles along the membrane contour were obtained by measuring over a
circular region 5 pixels thick, to reduce the noise. The mean ﬂuorescence
intensity along the GUV contour was deduced (IMEAN) as well as its SD (s).
To compare different GUVs, the ratio, s/IMEAN, is given and expressed in
percentage. Thus, for one experimental condition, this ratio calculated over
several GUVs quantiﬁes the heterogeneity of the membrane. The lowest it is,
the more homogeneous is on average the membrane of GUVs obtained in a
given experimental condition. The lowest ratio wasmeasured to bes/IMEAN¼
(8.7 6 1.1) % (see Fig. 4 A) and thus, clusters were deﬁned as areas of
membrane with intensities 15% higher than IMEAN.
z-Potential measurements
The average zpotential of the vesicles was measured on a Malvern Zeta Sizer
NanoZS (Malvern, Worcestershire, United Kingdom). The electrophoretic
mobility of GUVs (respectively LUVs) was measured at 0.05 mg/mL lipid
concentration (respectively 0.1 mg/mL) in the sucrose buffer and the
z-potential, j, of a vesicle, which is the electrostatic potential at the shear
plane, was calculated using the Helmholtz-Smoluchowski equation (34),
j ¼ ðuh=eRe0Þ; where u is the velocity of the vesicle in a unit electric ﬁeld
(between 50 and 150 V.cm1 for this conﬁguration); h is the viscosity of the
aqueous solution; eR is the dielectric constant of the aqueous solution; and e0
is the permittivity of free space. The z-potential is proportional to the surface
charge density (34). Numerical results are given as (mean 6 SD). For each
measurement, 750 mL of the GUV suspension were introduced in the mea-
surement cell. Three measurements were carried out for each sample from at
least two independent preparations. In fact, the SD on each measurement, as
given by the apparatus, were ;12% for GUVs and range from ;18% to
;100% for LUVs (higher SD when the potential was close to 0) and were
higher than the reproducibility of the measurement, which is of the order of
5% (for a given sample as well as for independent samples). Thus we plot as
error bars in the graph the SD for each measurement. The maximum size of
the vesicles that can be measured is;10 mm. To avoid sedimentation of the
GUVs, z-Potential measurements were carried out with GUVs suspended in
the sucrose buffer. For the sake of comparison, the same buffer was chosen
for the measurements on LUVs.
RESULTS
z-Potential of GUVs
In a ﬁrst step, we investigated the insertion of PIP2 in
membranes composed uniquely of DOPC or composed of a
mixture of DOPC and cholesterol (weight fraction, 15%), as
cholesterol has been reported to strengthen membranes
(35,36), and consequently to increase the stability and in-
tegrity of liposomes (37). GUVs were thus electroformed
with increasing percentages of PIP2 in the initial lipid mix-
ture, in the presence or in the absence of cholesterol. The
z-potential measurements were carried out within 2 h after
GUVs preparation (time T0) or 24 h after their preparation.
Fig. 1, A and B show the z-potential for DOPC and DOPC/
Chol GUVs, with various amounts of PIP2. For DOPC/PIP2
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GUVs, we observe that the initial z-potential decreases as the
percentage of PIP2 increases but reaches a plateau at;5% in
PIP2 (Fig. 1 A). We ﬁnd, however, noticeable differences
between the values measured within 2 h after GUVs elec-
troformation (T0) and 24 h later, indicating that the DOPC/
PIP2 GUVs may evolve during the storage period. In fact, the
z-potential of GUVs tends to rise with time as if PIP2 was
leaking from the GUV membrane. For DOPC/Chol/PIP2
GUVs, similarly to the GUVs without cholesterol, the
z-potential decreased steadily when PIP2 concentration is
increased (Fig. 1 B), which suggests that more and more PIP2
molecules are effectively incorporated in the membrane of
GUVs. A plateau in z-potential is reached for PIP2 percent-
ages higher than 8%. Interestingly, and in sharp contrast to
the GUVs without cholesterol, the GUVs containing cho-
lesterol seem to be stable over a duration of 24 h as their
z-potentials remain almost identical after 1 day in the storage
buffer (sucrose buffer). We also noticed that repeated mea-
surements on GUVs made from a lipid mixture containing
15% of cholesterol and 10% PIP2 lead to an increase in the
potential after ﬁve measurements have been carried out,
which suggests that GUVs containing high amounts of PIP2
are more fragile and might be more easily electroporated
(38). This effect was not observed when the PIP2 weight
fraction of the initial lipid mixture was decreased to 5%.
Thus, in the following, the total PIP2 percentage was ﬁxed
at 5% as the GUVs were stable in these conditions (no evo-
lution of the z-potential over repeated measurements).
Comparison of PIP2-containing GUVs with
PIP2-containing LUVs and with
POPS-containing GUVs
As LUVs have been most often used as biomimetic systems
to investigate PIP2/protein interactions (10,14,15), we com-
pared the z-potential of GUVs made by electroformation to
that of LUVs made by a rehydration method followed by
extrusion through a calibrated porous membrane, for the
same initial lipid compositions (Fig. 2 A). One ﬁnds that the
z-potential, j, of GUVs and of LUVs follows the same trend:
j decreases steadily on increase of the mass percent of PIP2 in
the initial lipid mixture. The z-potential of LUVs is related
linearly to that of GUVs with a slope of 0.86 (Fig. 2 B). Thus,
GUVs and LUVs can be considered to be similar in terms of
PIP2 insertion. However, the potentials of GUVs is system-
atically found lower than that of LUVs. We note that this
difference is observed even in the absence of PIP2. Indeed we
measured j; (17.26 2.0) mV for DOPC/Chol GUVs and
j; (6.96 6.3) mV for DOPC/Chol LUVs. These negative
values might be partly attributed to an effect of the buffer
(sucrose buffer without salt). In addition, the difference be-
tween LUVs and GUVs might arise from the fact that GUVs
have a ;1003 larger diameter than LUVs, which makes
them more deformable when placed in an electric ﬁeld (39).
Indeed, a prolate deformation of a GUV would presumably
decrease the drag force acting on the GUV; hence this would
increase its mobility, leading to an apparent larger surface
density and thus a more negative potential. Furthermore, the
deformation of GUVmay depend on the charge density of the
GUV: a GUV that possesses a higher charge density will
presumably deform more than a GUV with a weaker charge
density. Hence, we would expect the difference between the
z-potential of GUVs and that of LUVs to increase when the%
of PIP2 increases, as observed experimentally (Fig. 2 A).
POPS is often used as negatively charged lipid to mimic
the composition of the inner plasma membrane, either alone
or in combination with PIP2 (10,26). In addition, POPS has
been reported to bind nonspeciﬁcally to many types of pro-
teins, including MARCKS (40) and the matrix protein of
vesicular stomatitis virus (41). Thus, POPS-containing GUVs
prove as a useful control to check for nonspeciﬁc electrostatic
interactions between a protein and a negatively charged
lipidic membrane. The z-potential of GUVs fabricated from a
FIGURE 1 z-Potential of giant unilamellar vesicles (GUVs) as a function
of the mass percentage of PIP2 incorporated in the initial lipid mixture. The
electrophoretic mobility of GUVs composed of either DOPC/PIP2 (A) or
DOPC/Chol/PIP2 (B) was measured and the z-potential was calculated as
explained in the text, after the preparation of the GUVs (time T0) or 24 h
after their preparation. Values are (mean 6 SD) of the measurement.
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lipid mixture composed of DOPC, cholesterol and various
amounts of POPS (up to 20% in weight) have been measured.
Similarly to our ﬁndings with PIP2, we measured that the
z-potential decreases as the amount of POPS increases. It has
been reported that PIP2 has a net charge of3 and that POPS
has a net charge of 1 (20). Therefore, to directly compare
the results obtained with PIP2 and with POPS, we have
plotted in Fig. 2 C the two sets of data as a function of the
molar charge fraction of the initial lipid mixture. Both sets
of data are in good agreement and fall over a unique curve.
On the one hand, this indicates that the approximation of one
PIP2 equals 3 POPS (as far as the electric charge is con-
cerned) is valid. On the other hand, this conﬁrms the similar
incorporation of POPS and PIP2 in the membrane of GUVs
prepared by electroformation. This is consistent with our
observation that a saturation of the z-potential is measured for
mass fraction of PIP2 .8% (Fig. 1 B). In all cases, a limit to
the incorporation of negatively charged lipids into GUVs
made by electroformation seems to be set to a molar charge
fraction of;20%, hence a mass fraction of PIP2 of the order
of 8% (Fig. 2 C), whereas up to 20% of PIP2 can be in-
corporated in LUVs without evidence for a saturation of
the z-potential (22). This ﬁnding is in agreement with
previous reports that show that GUVs cannot be formed by
electroformation from a lipid mixture containing 20%
POPS (25).
Visualization of PIP2 in the membrane of GUVs
The effective incorporation of ﬂuorescent PIP2 can be qual-
itatively observed using BODIPY-labeled PIP2. Fluorescent
long-chain (C16) PIP2 analogs were used in this study be-
cause our initial attempts to insert the short-chain (C6)
BODIPY labeled PIP2 were always unsuccessful for both
TMR- and FL-PIP2. Moreover, we noticed that the long chain
ones did not incorporate into the GUVs membrane by elec-
troformation when experiments were carried out at 25C but
were incorporated when carried out at 38C (Fig. 3, A and B).
Finally, TMR-PIP2 was systematically found to exhibit a
preferential orientation in the membrane of GUVs, as shown
by a modulation linear with the square of the angle sine of the
azimuthal intensity, when the GUVs were observed with the
linearly polarized light of the laser of the confocal micro-
scope (42) (Fig. 3 B). A modulation of the intensity was never
observed for FL-PIP2 (Fig. 3 A). This difference has pre-
sumably to be attributed to the more hydrophobic and less
ﬂexible ﬂuorescent dye of the TMR-PIP2 molecule than that
of the FL-PIP2 molecule, which results in a more ordered
insertion of the TMR-PIP2 molecule in the lipid bilayer.
Noticeably, when TMR-PIP2 micelles were added to a sus-
pension of GUVs formed previously, TMR-PIP2 incorpo-
rated spontaneously the membrane of the GUVs, whereas
unlabeled PIP2 (as checked with PIP2 antibodies) or FL-PIP2
did not, as checked with PIP2 antibodies-labeling (data not
shown).
FIGURE 2 Comparison of GUVs with LUVs and of PIP2-GUVs with
POPS-GUVs. (A) z-Potential of GUVs as compared to that of LUVs with the
same initial lipid mixture (DOPC/Chol/PIP2) with various amounts of PIP2.
(B) z-Potential of LUVs plotted as a function of that of GUVs for a given %
of PIP2 in the initial lipid mixture for measurement made at 24 h (same data
as in Fig. 2 A). The linear regression has a slope of 0.86. (C) z-Potential of
GUVs electroformed from a lipid mixture containing increasing percentages
of PIP2 as compared to that of GUVs electroformed from a lipid mixture
containing increasing percentages of POPS. For direct comparison, the data
have been plotted on the same x axis as a function of the molar charge
density, considering that each POPS molecule possesses one charge and
each PIP2 molecule possesses three charges.
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FIGURE 3 Confocal microscopy observations of
PIP2 insertion in GUVs. (A and B) Direct observa-
tion of the GUVs by insertion (A) of 0.1% FL-PIP2
(C16) in the initial lipid mixture, DOPC/Chol/PIP2/
FL-PIP2 80:15:4.9:0.1, (B) of 0.1% TMR-PIP2
(C16) in the initial lipid mixture, DOPC/Chol/
PIP2/TMR-PIP2 80:15:4.9:0.1. Indirect observa-
tion of PIP2-containing GUVs (DOPC/Chol/PIP2,
(80:15:5) by immunolabeling with PIP2 secondary
(C) and tertiary (D) antibodies. In (C), RAM-Alexa
568 secondary ﬂuorescent antibodies were used. In
(D), unlabeled goat anti-mouse antibody (GAM)
followed by donkey anti-goat antibodies (tertiary
antibodies) coupled to Alexa 488 (DAG-Alexa 488)
were used. (E) Direct observation of FL-PIP2 for the
same GUVs as (D) (composition similar to A). Scale
bars: 10 mm. On the right hand side of the images,
the corresponding ﬂuorescence intensity proﬁles
along the GUV contour are plotted.
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Noticeably, the membrane of GUVs labeled with FL-PIP2
appears homogeneous without clusters. We measured
s/IMEAN¼ (9.86 1.9)% in the sucrose buffer, ands/IMEAN¼
(8.7 6 1.2) %, in the ezrin buffer. Hence, in the following,
s/IMEAN of the order of 10 was taken as the reference value
for a homogeneous labeling.
We also veriﬁed that the z-potential of GUVs made from a
lipid mixture containing 4.9% of unlabeled PIP2 and only a
trace (0.1%) of ﬂuorescent FL-PIP2 (j ¼ (47.36 5.6) mV)
was close to that of GUVs made from a lipid mixture con-
taining only 5% of unlabeled PIP2, (j ¼ (48.96 5.9) mV).
This indicates that the 0.1% of ﬂuorescent lipid inserted in the
membrane does not contribute to the overall potential, as
expected. It is important to note that TMR-PIP2 and FL-PIP2
are used here as tracers. Thus, only a very small fraction of %
of these lipids (,0.5%) is required to visualize the mem-
brane. Indeed, the limit of self-quenching of these lipids is
;1% of TMR-PIP2 (26) and 0.8% for BODIPY FL-PIP2
(Fig. S2 in Supplementary Material, Data S1), as determined
by ﬂuorescence spectroscopy of LUVs containing increasing
percentages of FL-PIP2.
Thus, in the following, the total PIP2 percentage was
ﬁxed at 5% as the GUVs and when ﬂuorescent PIP2 was
used, it was always added at 0.1% (2% of the total amount of
PIP2).
Alternatively, it is possible to visualize the presence of
PIP2 in the membrane by labeling it with primary antibodies
against PIP2 and then secondary antibodies coupled to a
ﬂuorescent dye (Fig. 3 C), or with unlabeled secondary an-
tibodies followed by labeled tertiary antibodies, to build
larger complexes (Fig. 3 D). We observed in this case the
presence of patches for labeled antibodies, an aspect with was
never observed for direct insertion of ﬂuorescent PIP2 (Figs.
3, A and B, and 4). More quantitatively, s/IMEAN ¼ (8.7 6
1.1) %, for FL-PIP2-labeling in the absence of PIP2 anti-
bodies (Fig. 3 A), s/IMEAN ¼ (27.4 6 6.5) % for ﬂuorescent
secondary antibodies (Fig. 3 C), and s/IMEAN ¼ (44.9 6
14.9) % (Fig. 3 D) for ﬂuorescent tertiary antibodies (Fig. 4,
three ﬁrst columns). Noticeably, when FL-PIP2 was observed
in the GUVs in contact with the tertiary antibodies, the
membrane of the GUVs appears more homogeneous than
when the ﬂuorescence of the tertiary antibodies is measured
(Fig. 3, E and D). We found s/IMEAN ¼ (19.5 6 7.5) % for
FL-PIP2 direct visualization, whereas s/IMEAN ¼ (44.9 6
14.9) % tertiary antibodies visualization (Fig. 4, 4th column).
Hence the apparent heterogeneous character of the membrane
of the GUV increases with the size of the detection molecule:
ﬂuorescent secondary antibodies might induce some PIP2
clustering, which is enhanced when larger anti-PIP2 com-
plexes (unlabeled secondary antibodies followed by the ad-
dition of ﬂuorescent tertiary antibodies) are used. However,
direct visualization of ﬂuorescent PIP2 and indirect visuali-
zation through antibodies, provide quantitatively different
results for clustering effects, which suggest that the clustering
effect visualized via antibodies is essentially artifactual.
Stability of GUVs in physiological medium and in
the presence of divalent ions
First, we veriﬁed that the size distribution of GUVsmade from
a lipid mixture containing 5% PIP2 was not different from that
of pure DOPC/Chol vesicles. The median diameter was 8 mm
for GUVs without PIP2 and 9 mm for GUVs with PIP2, as
evaluated by analyzing more than 160 GUVs for each con-
dition. As the GUVs prepared by electroformation were sus-
pended in a sucrose solution, a transfer in a physiological
mediumwas necessary if the GUVs had to be used for protein/
membrane studies (13,14). Therefore, we took care that the
osmolarity of the ezrin buffer into which the GUVs could
eventually be resuspended, (184 6 3) mOsm was slightly
higher than that of the initial sucrose buffer, (1746 3) mOsm,
so that the GUVs were always slightly deﬂated and therefore
ﬂuctuating (43). The transfer into a salty medium may render
the GUVs more fragile and with time could induce some
defects, in particular because of the existence of a trans-
membrane electric potential. However, we measured for
FL-PIP2- labeled GUVs that s/IMEAN¼ (9.86 1.9) % in the
sucrose buffer, (8.76 1.1) % just after immersion in the ezrin
FIGURE 4 Analysis of the heterogeneities in the GUV membranes. The
ratio of the SD of the ﬂuorescence signal along the GUV membrane divided
by the mean intensity of the GUV membrane (s/IMEAN) is given as mean6
SE for all the GUVs analyzed. The ﬁrst four columns correspond to ex-
periments carried out in the absence of ezrin in the following order: labeled
PIP2-GUVs using direct labeling or indirect labeling with secondary and
tertiary antibodies, (columns 1, 2, and 3, respectively). Column 4 is the ob-
servation of FL-PIP2 GUVs labeled with tertiary antibodies (observation in
the green channel whereas antibodies are observed in the red channel). The
last two columns correspond to images taken in the presence of ezrin in
solution: in this case, either ezrin-Alexa546 (column 5) or FL-PIP2 (column
6) were observed. All these experiments were carried out in the ezrin buffer.
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buffer, and (9.7 6 2.1) % after 2 h in this buffer. Thus, the
immersion in the ezrin buffer did not affect the homogeneity
of the GUV membrane.
In view of the investigation of biological phenomena, it is
crucial to quantify the stability of GUVs when put into
contact with divalent cations like Ca21 and Mg21 as these
ions are important in many physiological processes, includ-
ing interaction of several proteins, including annexin 2 with
membranes (14) and polymerization of actin (44). Indeed,
these ions have been reported to interact with the phosphate
groups of PIP2 (20). Thus, we investigated the contact of
these ions with PIP2-containing GUVs and labeled with FL-
PIP2. Before contact, the vesicles exhibited a homogenous
PIP2 distribution (Fig. 3 A). However, low amounts of Mg
21
and Ca21 (for concentrations .25 mM for Ca21 and .300
mM for Mg21) induced the formation of clusters leading to
s/IMEAN. 20% (Fig. 5, A–C). Interestingly, these clusters or
aggregates could only be observed in ﬂuorescence micros-
copy and were not visible by differential interference contrast
microscopy, which indicates that the formation of these
clusters is neither associated to a shape change of the GUVs
nor to a visible aggregation of the lipid membrane, but only to
PIP2 aggregation. When the ions concentrations were higher
(.300 mM for Ca21 and.1 mM for Mg21), vesicles rupture
within 10 min was also observed. We have plotted in Fig. 5 C
s/IMEAN as a function of the concentration of divalent ions in
the external medium (analysis was carried out 10 min after
addition of the ions). We found that, for both ions, the het-
erogeneity of the GUVs increases steadily. Fig. 5 C also
shows that GUVs were more sensitive to Ca21 than to Mg21.
PIP2-containing GUVs interact with ezrin
We subsequently investigated the interactions of the PIP2-
containing GUVs with ezrin, a protein that possesses a
FERM domain at its N-terminal and interacts with lipid
membranes via that domain. Indeed, ezrin has already been
shown to interact with PIP2-containing SLBs (12), with PIP2-
containing LUVs (22), and with giant vesicles made by the
gentle hydration method (27).
The PIP2-containing GUVs (composition of the initial
lipid mixture DOPC/Chol/PIP2, 80:15:5) were introduced in
a chamber containing ezrin, with a concentration in the range
of 14–22mM. Such high concentration of ezrin was chosen to
ensure that a large amount of protein was available for lipid
binding, as the afﬁnity of ezrin to PIP2-LUVs was found to be
;5 mM (22) (see details in Data S1). We observed that ezrin
localized at the membrane of GUVs only in the case where
PIP2 was inserted in the membrane (Fig. 6 B). When PIP2 was
replaced by POPS introduced at a higher percentage (15%) as
a negative control (Fig. 6 C), the membrane of GUVs was
never labeled, similarly to what was observed with pure
DOPC/Chol GUVs (Fig. 6 A). The mean radial concentration
proﬁle of ezrin (calculated for 14 GUVs in each condition)
quantiﬁes the increase of ezrin concentration in the close
vicinity of the membrane of GUVs when their membrane
appeared labeled (Fig. 6 D). The ﬂuorescence intensity of the
ezrin-labeled GUVsmembrane was at most 1.94 times higher
than the ﬂuorescence of the exterior, indicating that the local
FIGURE 5 Effect of divalent ions on PIP2-containing GUVs (composi-
tion of the initial lipid mixture DOPC/Chol/PIP2/FL-PIP2, 80/15/4.9/0.1).
Projections of a stack of images taken by confocal microscopy at different
height of GUVs in the glucose buffer (A) with 90 mMCa21; (B) with 90 mM
Mg21; (C) (s/IMEAN) for the GUVs as a function of the Ca
21 and Mg21
concentration in solution. Scale bar: 10 mm.
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ezrin concentration is roughly twice the concentration in the
bulk at most. We noticed that 23% of the GUVs were labeled
at their membrane (four independent experiments, 341 GUVs
observed in total), whereas for POPS, ,1% were labeled
(Table 2). Similar percentages of labeled GUVs were ob-
served for GUVs containing unlabeled PIP2 with or without
0.1% of FL-PIP2 (Table 2). This shows that FL-PIP2 does
not change the interaction properties of ezrin with PIP2-
containing GUVs. At present, there are only few quantitative
studies published on GUVs interacting with proteins. When a
thorough quantiﬁcation of the images is carried out, the
percentages measured for other proteins interacting with
PIP2-containing GUVs (27,45) fall in the range of what is
observed in this study. When GUVs were made from a initial
lipid mixture containing only DOPC and PIP2 (DOPC/PIP2
95/5) without cholesterol, this percentage fell to 7% (three
independent experiments, 208 GUVs counted) that might be
related to the highest and less stable z-potential values ob-
tained for these latter GUVs, as if PIP2 was incorporated in
smaller quantities or these membranes were less stable.
Importantly, we also veriﬁed that ezrin-Alexa488 and
ezrin-Alexa546 exhibited a similar behavior that did not
depend on the dye properties (Fig. 7). This is an important
point as recent experiments using a peptide (MARCKS 151-
175) labeled with either Alexa488 (a rather hydrophilic
moiety) or Texas Red (a more hydrophobic moiety) showed
that the Texas Red labeled peptide did permeate the mem-
brane of GUVs (membrane composition PC/PS/PIP2:
70:30:0.1) and was mostly located inside the GUVs whereas
Alexa488 labeled peptide did not permeate the membrane of
GUVs (26). These different observations are probably related
to the different size of the two proteins, ezrin being indeed
much larger than the MARCKS(151–175) peptide (24 amino
acids for the peptide versus 586 for ezrin) as well as to
the mode of interaction (electrostatic for MARKS, stereo-
speciﬁc for ezrin). In our case, we also conﬁrmed that the
percentage of labeled GUVs did not depend on the type of
FIGURE 6 Contact between GUVs and
ezrin (mixture containing 15 mM of WT
ezrin and 200 nM of ezrin-Alexa488). (A)
GUVs composed only of DOPC and cho-
lesterol (DOPC/Chol 85:15). (B) GUVs
containing PIP2 (DOPC/Chol/PIP2, 80:15:5).
(C) GUVs containing POPS as negatively
charged lipid (DOPC/Chol/POPS, 70:15:15).
(D) The radial concentration proﬁles of
ezrin for the three different types of GUVs
are represented after normalization (the dis-
tance r from the center of the GUV is nor-
malized by the radius of the vesicle R; the
ﬂuorescence intensity is normalized such as
it is equal to 0 inside the GUV and 1 in the
external medium.). Each proﬁle represents
the mean of 14 different proﬁles from indi-
vidual GUVs. The dotted vertical line shows
the range of values measured for the height
of the peak (between 1.15 and 1.94). The
scale is the same for the three pictures. Scale
bar: 10 mm.
TABLE 2 Quantiﬁcation of the number of ezrin-labeled
GUVs and of the presence of clusters for GUVs
of different composition
GUV composition
Ezrin-labeled GUV
(in % of the
total GUVs)
Presence of
clusters (in % of
labeled GUVs)
Ezrin-Alexa488
DOPC/Chol, 85:15 (n ¼ 222) 0 -
DOPC/Chol/POPS, 70:15:15
(n ¼ 90)
,1 -
DOPC/PIP2, 95:5 (n ¼ 208) 7 79
DOPC/Chol/PIP2 80:15:5
(n ¼ 537)
23 79
Ezrin-Alexa546
DOPC/Chol/PIP2/FL-PIP2 22 Visualization of
ezrin-Alexa546:81
80:15:4.9:0.1 (n ¼ 51) Visualization of
FL-PIP2:90
Clusters were deﬁned as areas with intensities 15% higher than the mean
GUV intensity along the contour length. n is the number of GUVs considered.
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dye. Thus, ezrin-Alexa488 and ezrin-Alexa546 interacted in
a similar way with PIP2-containing GUVs (Fig. 7 and Table
2). The heterogeneity of the GUVs membranes in the pres-
ence of ezrin (as quantiﬁed by the signal of FL-PIP2) was also
higher than for GUVs in the absence of ezrin (Fig. 4).We also
veriﬁed that, for a given GUV, s/IMEAN did not vary over the
observation period (;5 min).
When FL-PIP2 was used in combination with Ezrin-
Alexa546, we observed that FL-PIP2 and Ezrin-Alexa546
colocalized at the membrane of GUVs and that the distribu-
tion of both ezrin-Alexa546 and of FL-PIP2 appeared non
uniformwith local increase in concentrations in few clustered
regions (Figs. 8 and 4, last two columns). Indeed, we mea-
sured s/IMEAN ¼ (31.6 6 16.6) %, for FL-PIP2-labeling and
s/IMEAN ¼ (30.5 6 14.7) %, for ezrin-Alexa546-labeling.
DISCUSSION
Proof for the incorporation of PIP2 in GUVs
Membranes composed of a very limited number of constit-
uents, like DOPC, cholesterol, and PIP2 membranes are
often used as biomimetic systems to investigate the prop-
erties of PIP2 in the membrane (46) or the interactions of
proteins with the membrane (29). Fluorescent labeling by
incorporation of ﬂuorescent PIP2 at 0.1% and/or antibodies
that label only a very small fraction of the molecules (be-
tween 1:1000 to 1:10,000) is convenient for microscopy
observations but does not allow any quantitative determi-
nation of the degree of incorporation of PIP2 molecules in
the lipidic membrane of GUVs, whereas z-potential mea-
surements could. However, the quantitative incorporation of
PIP2 by z-potential measurements has only been proven for
multilamellar vesicles (20) and LUVs (22) thus far. This
technique is in fact used widely for physico-chemical and
pharmaceutical applications of small unilamellar vesicles
and LUVs (47), in particular to investigate their stability or
the adsorption of cations (48). To the best of our knowledge,
measurements of z-potential of GUVs have never been re-
ported in the literature previously. Thanks to our measure-
ments of the z-potential of GUVs, we were able to provide
evidence for i), the effective and quantitative incorporation
of PIP2 in GUVs; ii), the similar behavior of POPS and PIP2
in terms of incorporation by electroformation; and iii), a
good agreement between GUVs and LUVs prepared by
different preparation methods using identical lipid solu-
tions. z-Potential measurements appear thus as a new,
convenient and rapid tool to check for speciﬁc charged lipid
insertion in GUVs as well as to evaluate their stability in
time. Based on these measurements, we found that i), the
z-potential of the GUVs made from a lipid mixture con-
taining increasing amount of PIP2 decreases continuously
up to a saturation for 8% PIP2; and ii), GUVs made from a
lipid mixture containing DOPC, cholesterol, and PIP2 (DOPC/
chol/PIP2 80:15:5) are stable for a least 1 day.
Role of divalent ions
Investigating the stability of PIP2-containing GUVs is par-
ticularly important for future applications where actin or other
proteins have to be involved. In fact, PIP2 is known to interact
with many actin-binding proteins such as ERM proteins,
FIGURE 7 PIP2-containing GUVs (DOPC/Chol/
PIP2, 80:15:5) in contact with WT and ﬂuorescently
labeled ezrin (mixture containing 22 mM of WT
ezrin, 100 nM of ezrin-Alexa488, and 100 nM
of ezrin-Alexa546). (A) Observation of ezrin-
Alexa488 (green channel), (B) of ezrin-Alexa546
(red channel), and (C) merge of the green and red
channels. (D) The intensity proﬁle along the GUV
circumference is given for both channels (the ﬁrst
point of the lower proﬁle has been set arbitrary at
1 and the upper curve has been shifted for a better
visualization). The arrow indicates a cluster visible
in both channels. Scale bar: 10 mm.
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vinculin, talin, proﬁlin, WASP, and N-WASP (4) and bio-
mimetic systems appear as elegant tools to investigate speciﬁc
interactions of PIP2 and actin binding proteins (13,45). Thus, it
is important to fully characterize the behavior of PIP2-GUVs
in buffers such as F-actin buffer, which often contains 2 mM
MgCl2. In addition, several other proteins like annexins bind
to PIP2 in a Ca
21- dependent manner (14). Moreover, it is
known that divalent ions have an afﬁnity for the phosphate
groups of PIP2. Using multilamellar vesicles, McLaughlin
et al. (20) estimated the intrinsic association constant of cal-
cium with phosphate groups of PIP2 at ;500 M
1 for Ca21
ions and ;100 M1 for Mg21 ions. These authors also
showed that calcium concentrations ,100 mM do not affect
signiﬁcantly the z-potential of PC/PIP2 vesicles. Our results
show that Ca21 and Mg21 induce signiﬁcant PIP2 clustering
when added at ;30 mM for Ca21 and ;300 mM for Mg21.
Thus, one has to keep in mind that clusters of PIP2 might pre-
exist when studying GUVs/protein interactions in a F-actin
buffer. However, the cellular concentrations of calcium are
well below those exerting a deleterious effect on GUVs and
most of the magnesium added in the F-actin buffer is com-
plexed with adenosine 59 triphosphate, as in the cell, and
should not alter the stability of GUVs.
Insertion of synthetic ﬂuorescent PIP2 in
the membrane
We showed that long-chain (C16) BODIPY-labeled syn-
thetic PIP2 molecules are needed to get an effective incor-
poration of these molecules in the membrane of GUVs and
that short-chain (C6)-labeled synthetic PIP2 did not enter the
membrane of GUVs. As observed previously with experi-
ments using LUVs, this simply reﬂects that a long, more
hydrophobic acyl chain will incorporate a lipid membrane
much more easily and will have more difﬁculty escaping
from it than a short, less hydrophobic one (45,48,49) Inter-
estingly, these previous results on LUVs seem to extend to
membranes of GUVs as well as, to some extent, to cellular
membranes. Thus, Bagatolli et al. (29) found that short-
chains TMR and FL-PIP2 do not partition well into the
membrane of a GUV. Cho et al. (49) also noticed that the
short C6 BODIPY-labeled phosphoinositides were not well
localized to the surface membrane but were found equally in
cytoplasm. Furthermore, our observations of uniform distri-
butions of TMR-PIP2 and FL-PIP2 in GUVs membranes
(Fig. 3, A and B) suggest that PIP2 molecules do not form
domains in DOPC/Chol membranes. This is in agreement
with the experimental ﬁndings of Fernandez et al. (46) with
LUVs and Herrig et al. (12) with PIP2-containing SLBs.
Protein/GUVs interactions
We used ezrin, a ERM protein, as a model protein for visu-
alizing interactions of proteins with PIP2-containing GUVs.
This protein has been used recently to investigate the hole-
opening activity of ERM proteins in the membranes of
GUVs. In a previous study, Takeda et al. (27) found that high
FIGURE 8 Contact between PIP2-containing
GUVs labeled with FL-PIP2 and ezrin-Alexa546.
(A) Observation of a GUV containing 0.1% FL-
PIP2 (DOPC/Chol/PIP2/FL-PIP2, 80:15:4.9:0.1).
(B) Same vesicle as in (A) observed in the red
channel for visualization of ezrin-Alexa546. (C)
Merge of the two images. (D) Intensity proﬁles for
each channel along the circumference of the GUV
(the upper curve has been shifted for better visual-
ization). Scale bar: 10 mm.
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concentrations of ezrin (15 mM) were able to open holes in
the membranes of GUVsmade of phosphatidylcholine and of
an anionic lipid phosphatidylglycerol at a 1:1 molar ratio, in a
low ionic strength medium. Importantly, ezrin-induced hole
formation was insensitive to cholesterol added in the mem-
brane but was sensitive to PIP2 insertion in the membrane. In
this latter case, the hole-opening activity was abolished for
GUVs containing 10% PIP2. Thus, although carried out in a
different suspending medium for GUVs of different lipid
composition, our experiments conﬁrm that ezrin does not
induce hole in liposomal membranes containing PIP2.
Why relatively high concentrations of ezrin are needed to
effectively observe an interaction of ezrin with the membrane
of GUVs can be understood from the knowledge of the af-
ﬁnity (;5 mM for ezrin interaction with PIP2-containing
LUVs (22)) and from the known concentration of lipid in
solution. In our experimental conditions, using 15 mM ezrin,
80% of the PIP2 molecules are expected to be bound (Fig. S1
in Data S1), whereas ,2.7% of ezrin will be bound. This
would explain the proﬁles given in Fig. 6 D, which shows
that for GUVs labeled with ﬂuorescent ezrin, the local con-
centration of ezrin at the membrane is at most about twice the
bulk concentration of ezrin.
In addition, our observations suggest that ezrin might be
able to reorganize the PIP2 molecules incorporated in the
membrane of GUVs upon interaction. Ezrin appears clus-
tered in some places (Figs. 4 and 6–8). Such clustering was
already observed by AFM for ezrin interacting with a SLB
containing 3% of PIP2 and was attributed to protein/protein
interactions at the membrane surface (12). Indeed, we found
that GUVs observed via PIP2 antibodies, PIP2 appear clus-
tered, this clustering being enhanced as the size of the de-
tection complex was increased (Figs. 3, C and D, and 4). A
noticeable difference appears when FL-PIP2 was observed on
the same GUVs (the tertiary antibodies being observed in the
red channel): a more homogeneous distribution is visible in
the green channel, where the FL-PIP2 is detected (compare
column 3 and 4 in Fig. 4 A). This suggests that the clustering
effect observed using antibodies is essentially artifactual and
results from the building of large complexes.
CONCLUSIONS
z-Potential measurements allow one to follow unlabeled PIP2
insertion in the membrane of GUVs fabricated by the elec-
troformation technique. Long-chain (C16) ﬂuorescent PIP2
analogs (TMR-PIP2 and FL-PIP2) were used as tracers
(0.1%) for visualizing the membrane by confocal micros-
copy. The homogeneity of the membrane of PIP2-containing
GUVs was quantiﬁed using the SD of the ﬂuorescence in-
tensity along the GUV contour and was found to depend of
the method of observation: antibodies against PIP2 appear
clustered, the clustering depending on the size of the anti-
bodies, whereas TMR- and FL-PIP2 appear homogenously
distributed in the membrane. The PIP2-containing GUVs
were used for subsequent ezrin/GUVs interaction studies
using either ﬂuorescently-labeled GUVs, ﬂuorescently-
labeled ezrin, or both. Ezrin was found to interact with the
GUVs leading to a reorganization of PIP2 on interaction.
Ezrin bound similarly to GUVs containing only unlabeled
PIP2 or unlabeled PIP2 with 0.1% FL-PIP2. Besides a number
of transmembrane ligands, ezrin is also an actin binding
protein, which justiﬁes its role as a membrane-cytoskeleton
linker (50). We believe the characterization of a biomimetic
system presented in this study is obviously the ﬁrst step for
understanding the mechanisms of the morphogenic proper-
ties of ezrin. More widely, these biomimetic vesicles can also
be used for investigation of phosphoinositide containing
GUVs with several other types of proteins.
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